These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24586533)

  • 1. Topoisomerase inhibitors modulate gene expression of B-cell translocation gene 2 and prostate specific antigen in prostate carcinoma cells.
    Chiang KC; Tsui KH; Chung LC; Yeh CN; Chang PL; Chen WT; Juang HH
    PLoS One; 2014; 9(2):e89117. PubMed ID: 24586533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways.
    Chiang KC; Tsui KH; Chung LC; Yeh CN; Feng TH; Chen WT; Chang PL; Chiang HY; Juang HH
    Sci Rep; 2014 Jul; 4():5511. PubMed ID: 24981574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
    Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH
    Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells.
    Tsui KH; Chiang KC; Lin YH; Chang KS; Feng TH; Juang HH
    Cancer Med; 2018 Jan; 7(1):184-195. PubMed ID: 29239139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells.
    Chung LC; Tsui KH; Feng TH; Lee SL; Chang PL; Juang HH
    Am J Physiol Cell Physiol; 2012 Feb; 302(4):C676-85. PubMed ID: 22116304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BTG2 is an LXXLL-dependent co-repressor for androgen receptor transcriptional activity.
    Hu XD; Meng QH; Xu JY; Jiao Y; Ge CM; Jacob A; Wang P; Rosen EM; Fan S
    Biochem Biophys Res Commun; 2011 Jan; 404(4):903-9. PubMed ID: 21172304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2.
    Tsui KH; Hsieh WC; Lin MH; Chang PL; Juang HH
    Prostate; 2008 May; 68(6):610-9. PubMed ID: 18196550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells.
    Tsui KH; Chang YL; Feng TH; Hou CP; Lin YH; Yang PS; Lee BW; Juang HH
    Prostate; 2018 Mar; 78(4):242-249. PubMed ID: 29164633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells.
    Hsu JC; Zhang J; Dev A; Wing A; Bjeldanes LF; Firestone GL
    Carcinogenesis; 2005 Nov; 26(11):1896-904. PubMed ID: 15958518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer.
    Rokhlin OW; Scheinker VS; Taghiyev AF; Bumcrot D; Glover RA; Cohen MB
    Cancer Biol Ther; 2008 Aug; 7(8):1288-96. PubMed ID: 18497571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
    Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
    Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-androgen receptor signaling and prostate cancer inhibitory effects of sucrose- and benzophenone-compounds.
    Wang Z; Lee HJ; Wang L; Jiang C; Baek NI; Kim SH; Lü J
    Pharm Res; 2009 May; 26(5):1140-8. PubMed ID: 19266268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
    Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
    Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis.
    Ficazzola MA; Fraiman M; Gitlin J; Woo K; Melamed J; Rubin MA; Walden PD
    Carcinogenesis; 2001 Aug; 22(8):1271-9. PubMed ID: 11470758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.
    Cinar B; Yeung F; Konaka H; Mayo MW; Freeman MR; Zhau HE; Chung LW
    Biochem J; 2004 Apr; 379(Pt 2):421-31. PubMed ID: 14715080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of P53-Senescence Induction in Suppression of LNCaP Prostate Cancer Growth by Cardiotonic Compound Bufalin.
    Zhang Y; Dong Y; Melkus MW; Yin S; Tang SN; Jiang P; Pramanik K; Wu W; Kim S; Ye M; Hu H; Lu J; Jiang C
    Mol Cancer Ther; 2018 Nov; 17(11):2341-2352. PubMed ID: 30166403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells.
    Chung LC; Tsui KH; Feng TH; Lee SL; Chang PL; Juang HH
    Mol Nutr Food Res; 2011 Nov; 55(11):1666-76. PubMed ID: 21936051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
    Sadar MD; Gleave ME
    Cancer Res; 2000 Oct; 60(20):5825-31. PubMed ID: 11059779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage.
    Lim YB; Park TJ; Lim IK
    J Biol Chem; 2008 Nov; 283(48):33110-8. PubMed ID: 18840609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells.
    Lin HP; Lin CY; Hsiao PH; Wang HD; Jiang SS; Hsu JM; Jim WT; Chen M; Kung HJ; Chuu CP
    PLoS One; 2013; 8(12):e82625. PubMed ID: 24349321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.